SCHEMBL2935932

SCHEMBL2935932

COc1ccccc1C(C)Nc1ccc2c(N)cccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ADRA2B P18089 1/20 0.41
PTGS1 P23219 1/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
HIF1A Q16665 2/20 0.41
HTT P42858 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ACHE P22303 1/20 0.41
SOS1 Q07889 7/20 0.41
KRAS P01116 6/20 0.41
EGFR P00533 2/20 0.41
GBA1 P04062 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NCF1 P14598 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909092 0.72 MAP2K4 (0.42) ALDH1A1MEN1MAPTKMT2ASOS1
SCHEMBL14451009 0.69 NCF1 (0.50) ADRA2BSOS1KRASEGFRNCF1
SCHEMBL21217198 0.69 NCF1 (0.53) TDP1ALDH1A1MEN1MAPTKMT2A
SCHEMBL27060737 0.69 NCF1 (0.65) TDP1ALDH1A1MEN1KMT2ANCF1
SCHEMBL10933460 0.68 CA1 (0.53) TDP1ALDH1A1MEN1MAPTKMT2A
SCHEMBL2905912 0.68 MCHR1 (0.39) ACHEEGFRADORA2A
SCHEMBL18319393 0.68 CA1 (0.43) TDP1ALDH1A1ADRA2BPTGS1CA1
SCHEMBL9406798 0.68 POLB (0.56) TDP1ALDH1A1ADRA2BPTGS1MEN1
SCHEMBL8023509 0.67 ALDH1A1 (0.46) TDP1ALDH1A1MEN1MAPTKMT2A
SCHEMBL3532637 0.67 HTR3A (0.46) TDP1ALDH1A1ADRA2BPTGS1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US disclosed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP disclosed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES AR, ADRA2C, RCC2 TDP1 1720/4885ALDH1A1 872/4885ADRA2B 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.